Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis.
Theodoros KarampitsakosOurania PapaioannouIlias DimeasPanagiota TsiriVasilina SotiropoulouIoannis TomosIlias C PapanikolaouMatthaios KatsarasParaskevi KirgouZoe DaniilKonstantinos I GourgoulianisFotios SampsonasEffrosyni ManaliSpyridon PapirisDemosthenes BourosArgyris TzouvelekisPublished in: ERJ open research (2022)
Patients with #IPF do not mount appreciable anti-spike antibody responses to two doses of #SARSCoV2 mRNA vaccine compared to the general population. National authorities should prioritise patients with IPF for booster doses. https://bit.ly/3K2KXQ0.